Zhi Yuan Chang
Director Ejecutivo en Chongqing Genrix Biopharmaceutical Co., Ltd. .
Fortuna: 14 M $ al 30/04/2024
Perfil
Zhi Yuan Chang has worked as the General Manager & Director at Chongqing Genrix Biopharmaceutical Co., Ltd.
since 2021.
Participaciones conocidas en empresas públicas
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
Chongqing Genrix Biopharmaceutical Co., Ltd.
 Chongqing Genrix Biopharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Chongqing Genrix Biopharmaceutical Co., Ltd. principally engages in the research, development, production, and sale of antibody drugs. Its key antibody drugs are mainly for autoimmune diseases, infectious diseases, and tumors. The company was founded on October 20, 2015 and is headquartered in Chongqing, China. 0.90% | 30/06/2023 | 2 500 000 ( 0.90% ) | 14 M $ | 30/04/2024 |
Cargos activos de Zhi Yuan Chang
| Empresas | Cargo | Inicio |
|---|---|---|
Chongqing Genrix Biopharmaceutical Co., Ltd.
Chongqing Genrix Biopharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Chongqing Genrix Biopharmaceutical Co., Ltd. principally engages in the research, development, production, and sale of antibody drugs. Its key antibody drugs are mainly for autoimmune diseases, infectious diseases, and tumors. The company was founded on October 20, 2015 and is headquartered in Chongqing, China. | Director Ejecutivo | 01/10/2015 |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 1 |
|---|---|
 | Health Technology |
- Bolsa de valores
- Insiders
- Zhi Yuan Chang
